In light of the major role played by the non-glycemic diseases of T2D in profiling T2D morbidity and mortality as well as in promoting T2D comorbidities (e.g., cancer, neurodegeneration, other), chronic insulin doses should be carefully considered beyond its risk of hypoglycemia. Here, INS is linked to type 2 diabetes mellitus.